Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessGonorrhea

Impact of antenatal screening for Chlamydia and Gonorrhea on pregnancy outcomes in South African women

BMC Infectious Diseases·

Dorothy Chiwoniso Nyemba, Alex de Voux, Rufaro Mvududu, Remco P. H. Peters, Sinead Delany-Moretlwe, Leigh F. Johnson, Thomas J. Coates, Landon Myer, Dvora Leah Joseph Davey

DOI
10.1186/s12879-026-13967-3
PMID
42481976
PMCID
OpenAlex
W7169844332
Study type
Journal article
Publisher
Springer Science and Business Media LLC
Article type
journal-article
Integrity
current

Why this research matters now

The findings suggest potential benefits of STI screening using diagnostic tests that enable timely treatment of curable STIs during pregnancy to reduce adverse pregnancy outcomes.

01

Structured evidence summary

Research question

The study evaluated whether diagnosing and treating chlamydia and gonorrhea during pregnancy affects adverse pregnancy outcomes in South African women.

Study design

Eligible pregnant women without HIV, attending their first antenatal care visit before 28 weeks gestation, received diagnostic testing at enrollment and either same-day or follow-up treatment using on-site GeneXpert or laboratory-based TaqMan qPCR assays. The study assessed STI prevalence, time to treatment, and frequency of poor pregnancy outcomes including miscarriage and stillbirth.

Population and setting

The study enrolled 1237 pregnant women aged 15 years or older without HIV in Cape Town, South Africa, who were attending their first antenatal care visit before 28 weeks gestation.

Main findings

Among 1237 pregnant women, 28% tested positive for chlamydia or gonorrhea at first antenatal care visit. Of those diagnosed, 54% received immediate treatment. Untreated chlamydia or gonorrhea during pregnancy increased the odds of experiencing a miscarriage or stillbirth.

Public-health relevance

The findings suggest potential benefits of STI screening using diagnostic tests that enable timely treatment of curable STIs during pregnancy to reduce adverse pregnancy outcomes.

Important limitations

The authors note that randomized trials are urgently needed to clarify the effects observed in this study. This summary is limited to the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation.

GIDS interpretation

This article was discovered through classifier links to gonorrhea, South Africa, diagnostics, and treatment. It provides evidence on antenatal screening approaches and their association with pregnancy outcomes in a high-burden setting.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 10 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicevaluates interventionevaluates interventionstudied instudied population settingstudies populationstudies populationuses study design